Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transgenic RNA interference in mice.

Xue Gao1, Pumin Zhang

  • 1Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, USA.

Physiology (Bethesda, Md.)
|June 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The deubiquitinase USP28 promotes esophageal squamous cell carcinoma proliferation by stabilizing ΔNp63 protein.

Cellular signalling·2026
Same author

UHRF1 Controls the Timing of RAD51 Removal During DNA Damage Repair Through Suppressing RFWD3.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Targeting IDH2 promotes antitumor immunity through epigenetic activation of cGAS-STING pathway.

Lung cancer (Amsterdam, Netherlands)·2025
Same author

USP25 maintains KRAS expression and inhibiting the deubiquitinase suppresses KRAS signaling in human cancer.

The Journal of biological chemistry·2025
Same author

Advances in preclinical and clinical studies of oncolytic virus combination therapy.

Frontiers in oncology·2025
Same author

The deubiquitinase USP28 maintains the expression of PPARγ and its inactivation protects mice from diet-induced MASH and hepatocarcinoma.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same journal

Evolution of Adaptive Non-Shivering Thermogenesis in Mammals.

Physiology (Bethesda, Md.)·2026
Same journal

The Iron Lung: Ferroptosis and Iron Regulation in Aging and Lung Diseases.

Physiology (Bethesda, Md.)·2026
Same journal

RNA-Protein complexes and their role in cell fate.

Physiology (Bethesda, Md.)·2026
Same journal

Ion Channels as Gatekeepers of Fertility: From Uterine Kir7.1 to Sperm CatSper.

Physiology (Bethesda, Md.)·2026
Same journal

Is insulin resistance an adaptive response? Clues from nature.

Physiology (Bethesda, Md.)·2026
Same journal

Physiology in Perspective.

Physiology (Bethesda, Md.)·2026
See all related articles

Small hairpin RNA (shRNA) expressed from vectors offers sustained gene silencing for research and therapeutic applications. Transgenic RNA interference (RNAi) mice enable in vivo studies and chronic treatment potentials.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biomedical Research

Background:

  • Small interfering RNA (siRNA) enables gene silencing in mammalian cells, primarily for studying gene function in vitro.
  • The transient nature of siRNA necessitates alternative methods for sustained gene silencing.
  • Small hairpin RNA (shRNA) expressed from vectors provides a more durable gene knockdown effect.

Purpose of the Study:

  • To review the advancements in generating transgenic RNA interference (RNAi) mice.
  • To highlight the potential of transgenic RNAi for in vivo research and therapeutic applications.

Main Methods:

  • Utilizing shRNA-expressed vectors for sustained gene silencing.
  • Employing transgenic technology for in vivo delivery of shRNA-expressing vectors.

Related Experiment Videos

  • Developing transgenic RNAi models in mice.

    • Main Results:

    • Transgenic RNAi allows for the investigation of biological processes not observable in cell cultures.
    • This technology demonstrates potential for chronic therapeutic interventions.
    • Significant progress has been made in the generation of transgenic RNAi mice.

    Conclusions:

    • Transgenic RNAi, particularly in mouse models, offers a powerful tool for both fundamental biological research and the development of novel therapeutics.
    • The shift from transient siRNA to sustained shRNA expression via transgenic technology broadens the scope of RNAi applications.